Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 7, 2020; 26(21): 2810-2820
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2810
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2810
Figure 3 Gan Shen Fu Fang inhibited HSC-T6 cell viability and collagen synthesis.
A and B: GSFF inhibited HSC-T6 cell viability and Col. I release; C and D: GSFF inhibited the viability and Col. I release of HSC-T6 cells stimulated with transforming growth factor β1 (TGF-β1); E and F: TGF-β1 promoted α-SMA expression in HSC-T6 cells, which was decreased by GSFF. The relative α-SMA content was measured by quantitative histomorphometry, and the results are shown in panel E. aP < 0.05, bP < 0.01, compared with the control cells. cP < 0.05, dP < 0.01, fP < 0.001, compared with cells stimulated with TGF-β1 only. GSFF: Gan Shen Fu Fang; TGF-β1: Transforming growth factor β1.
- Citation: Du QH, Zhang CJ, Li WH, Mu Y, Xu Y, Lowe S, Han L, Yu X, Wang SY, Li Y, Li J. Gan Shen Fu Fang ameliorates liver fibrosis in vitro and in vivo by inhibiting the inflammatory response and extracellular signal-regulated kinase phosphorylation. World J Gastroenterol 2020; 26(21): 2810-2820
- URL: https://www.wjgnet.com/1007-9327/full/v26/i21/2810.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i21.2810